<?xml version="1.0" encoding="UTF-8"?>
<p>In our study and others, up to &gt;20% patients with viral pneumonia had a bacterial copathogen [
 <xref rid="CIT0004" ref-type="bibr">4</xref>]. This increases the difficulty in identifying patients not requiring antibacterial coverage in patients with confirmed viral pneumonia. Adopting more sensitive diagnostic tools for detection of bacterial pathogens, or using serum biomarkers such as procalcitonin, may guide optimal treatment decisions [
 <xref rid="CIT0004" ref-type="bibr">4</xref>, 
 <xref rid="CIT0015" ref-type="bibr">15</xref>].
</p>
